Carissa Chu discusses her Prostate Cancer Foundation Young Investigator Award work on STEAP1-targeted bispecific T-cell engagers. Dr. Chu explains that STEAP1, a six-transmembrane surface protein, is ...

Andrew Hahn discusses HLD-0915, a first-in-class Regulated Induced Proximity TArgeting Chimera (RIPTAC™) therapy for metastatic castration-resistant prostate cancer. Dr. Hahn explains that RIPTACs ...

Andrew Hahn discusses the LenCabo study, a randomized phase 2 trial comparing lenvatinib plus everolimus versus cabozantinib for metastatic clear cell renal cell carcinoma progressing on PD-1 ...

Ashish Kamat: Yeah, and speaking of high quality information, you're going to enlighten us today on something that has really taken off in the last three or four years. I mean, we've been doing liquid ...

Wallace BK, Su ZT, Flynn JP, Garman TS, Weitzner A, Rezaee ME, et al. National trends in diagnoses of subtype histologies in bladder cancer: A population-based study based on the SEER database. Urol ...

In this discussion, Matthew Cooperberg, MD, speaks with Monique Roobol, PhD, lead author of the NEJM publication “European Study of Prostate Cancer Screening - 23-Year Follow-up.” Dr. Roobol reviews ...

Oliver Sartor: Hi, I'm Oliver Sartor with Uro Today, covering metastatic castration resistant prostate cancer at ASCO 2025. A real delight for me to welcome Mark Stein, associate professor at Columbia ...

Scott Sellinger discusses federal government shutdown impacts on healthcare delivery with Phillip Koo, highlighting critical operational challenges facing independent urology practices. Medicare ...

At the 2025 UCSF-UCLA PSMA Conference, Vadim Koshkin discusses radioligand therapies for bladder cancer. He highlights that gallium-FAP-2286 imaging shows bladder cancer has the highest FAP uptake ...

Login to update email address, newsletter preferences and use bookmarks.

At the 2025 UCSF-UCLA PSMA Conference, Michael Hofman discusses his team's work with Terbium-161 in the VIOLET clinical trial at Peter Mac. He explains Terbium-161 offers both beta and Auger electron ...

At the 2025 UCSF-UCLA PSMA Conference, Alfred Morgenstern discusses his work with actinium-PSMA therapy for prostate cancer. He reviews clinical programs including Mike Sathekge's work with ...